Retension Pharmaceuticals, Inc. · NASDAQ:RTSN
Eric Keller bought 20,800 Retension Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 13, 2026 · Filed Oct 13, 2026
On Oct 13, 2026, Eric Keller (Director, CHIEF EXECUTIVE OFFICER) bought 20,800 Retension Pharmaceuticals, Inc. shares at US$12.00 for US$250K, leaving 464,407 shares. Filed Oct 13, 2026 (Form 4).
- Bought
- 20,800 shares
- Price
- US$12.00
- Value
- US$250K
- Holding after
- 464,407 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Common Stock | Buy | 20,800 | US$12.00 | 423,377 | Direct |
| Oct 13, 2026 | Common Stock | Conversion | 9,662 | 433,039 | Direct | |
| Oct 13, 2026 | Common Stock | Conversion | 31,368 | 464,407 | Direct |
Source
Related
- Retension Pharmaceuticals, Inc.
- Eric Keller
- Retension Pharmaceuticals, Inc. shareholders
- Schedule 13G · Pvg Asset Management Corp · Oct 16, 2026
- Schedule 13G · B Group, Inc. · Oct 16, 2026
- Schedule 13G · Laurence W. Lytton · Oct 15, 2026
- Schedule 13D · Eric Keller · Oct 14, 2026
- Form 4 · Berendt Michael J · Oct 13, 2026